The Centre for Cellular and Molecular Platforms (C-CAMP) has announced a next-generation tripartite Indo-European collaboration to address the challenges posed by Antimicrobial Resistance (AMR), with science, innovation, policy, and stewardship.
According to C-CAMP, antibiotics such as penicillin are pillars of modern medicine that have enabled decades of healthcare advances. However indiscriminate use of antibiotics over time in food systems, agriculture, and health have now brought us to a situation where vulnerable populations particularly neonates, elderly, and immunocompromised are greatly exposed to life-threatening, intractable infections.
A UN report projects an annual loss of nearly 10 million lives globally by 2050 due to AMR.
